Ryan Specialty Holdings, Inc. (NYSE:RYAN) Shares Sold by Townsquare Capital LLC

Townsquare Capital LLC cut its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 29.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 171,517 shares of the company's stock after selling 73,198 shares during the period. Townsquare Capital LLC owned approximately 0.07% of Ryan Specialty worth $11,005,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in RYAN. Rakuten Securities Inc. bought a new stake in shares of Ryan Specialty during the 4th quarter valued at about $27,000. Principal Securities Inc. grew its position in Ryan Specialty by 164.7% during the fourth quarter. Principal Securities Inc. now owns 667 shares of the company's stock valued at $43,000 after buying an additional 415 shares during the period. Mizuho Bank Ltd. purchased a new stake in Ryan Specialty during the fourth quarter valued at approximately $49,000. Headlands Technologies LLC raised its position in Ryan Specialty by 2,644.8% in the fourth quarter. Headlands Technologies LLC now owns 796 shares of the company's stock worth $51,000 after acquiring an additional 767 shares during the period. Finally, Harvest Fund Management Co. Ltd purchased a new position in shares of Ryan Specialty during the 4th quarter worth $54,000. Institutional investors own 84.82% of the company's stock.

Ryan Specialty Price Performance

Shares of RYAN traded down $1.46 during mid-day trading on Friday, hitting $70.63. 967,494 shares of the stock were exchanged, compared to its average volume of 942,994. The firm has a 50-day moving average of $70.38 and a two-hundred day moving average of $69.02. Ryan Specialty Holdings, Inc. has a 52-week low of $48.48 and a 52-week high of $77.16. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. The company has a market cap of $18.50 billion, a PE ratio of 102.37, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analysts' expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. On average, equities analysts predict that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Tuesday, March 4th were paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 0.68%. This is a positive change from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty's dividend payout ratio (DPR) is presently 69.57%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. TD Cowen began coverage on Ryan Specialty in a report on Thursday, April 10th. They issued a "buy" rating and a $89.00 target price on the stock. Wells Fargo & Company cut their price objective on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating for the company in a research note on Thursday, April 10th. Keefe, Bruyette & Woods reduced their target price on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a report on Wednesday, April 9th. UBS Group lifted their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a report on Wednesday, February 26th. Finally, Royal Bank of Canada reduced their price objective on shares of Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating for the company in a research note on Friday, February 21st. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $75.67.

Insider Transactions at Ryan Specialty

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 10,485 shares of the business's stock in a transaction that occurred on Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total transaction of $682,783.20. Following the completion of the transaction, the director now owns 11,109 shares in the company, valued at $723,418.08. The trade was a 48.56 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Brendan Martin Mulshine sold 30,000 shares of the stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 141,894 shares of company stock worth $9,429,470. 11.10% of the stock is currently owned by company insiders.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.